Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Surface Oncology Inc
(NQ:
SURF
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.030 (21)
Ask (Size)
1.090 (10)
Prev. Close
1.070
Today's Range
N/A - N/A
52wk Range
0.9302 - 1.120
Shares Outstanding
45,452,450
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
August 31, 2023
Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting
From
Surface Oncology, Inc.
Via
GlobeNewswire
SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
August 07, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
More News
Read More
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
August 02, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Health Care Company Coherus BioSciences Announces Merger With Surface Oncology
June 16, 2023
Via
Benzinga
Recap: Surface Oncology Q1 Earnings
May 04, 2023
Via
Benzinga
Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares
July 27, 2023
Via
Benzinga
Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades
July 11, 2023
Via
Benzinga
Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made
June 28, 2023
Via
Benzinga
Cathie Wood Sells $7M Tesla Stock Friday Amid Pullback, Bets Big On This Crypto-Linked Stock
June 24, 2023
Via
Benzinga
SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
June 21, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability
June 20, 2023
Via
Benzinga
Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June
June 16, 2023
Via
Benzinga
Crude Oil Rises; Adobe Posts Upbeat Results
June 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
June 20, 2023
Via
Benzinga
Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday
June 16, 2023
Via
Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 16, 2023
Via
Benzinga
SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders
June 16, 2023
From
Halper Sadeh LLC
Via
Business Wire
US Stocks Mixed; Dow Gains 50 Points
June 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 16, 2023
Via
Benzinga
Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M
June 16, 2023
Via
Benzinga
Coherus to Acquire Surface Oncology
June 16, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
May 04, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
April 18, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023
March 16, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022
March 09, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.